Clinical Trials Browser

Phase 1/2 × Pancreatic Adenocarcinoma × 130-nm albumin-bound paclitaxel × Clear all

NCT03193190 2025-11-21

A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)

Phase 1/2 Completed

341 enrolled 28 charts

Gastrointestinal

Pancreatic Adenocarcinoma